Mohamad Mroué

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Neuropathic Pain

Helicobacter Pylori

Neuroendocrine Tumors

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Mohamad Mroué, Flavien Bessaguet, Angélique Nizou, Laurence Richard, Franck G Sturtz, Laurent Magy, Sylvie Bourthoumieu, Aurore Danigo, Claire Demiot
Neuroprotective Effect of Polyvalent Immunoglobulins on Mouse Models of Chemotherapy-Induced Peripheral Neuropathy. Pharmaceutics 16 (1) (2024)
Amandine Bernard, Mohamad Mroué, Sylvie Bourthoumieu, Malcolm Boyce, Laurence Richard, Franck G Sturtz, Claire Demiot, Aurore Danigo
Netazepide, an Antagonist of Cholecystokinin Type 2 Receptor, Prevents Vincristine-Induced Sensory Neuropathy in Mice. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Mohamad Mroué, Flavien Bessaguet, Angélique Nizou, Laurence Richard, Franck G Sturtz, Laurent Magy, Sylvie Bourthoumieu, Aurore Danigo, Claire Demiot
Neuroprotective Effect of Polyvalent Immunoglobulins on Mouse Models of Chemotherapy-Induced Peripheral Neuropathy. Pharmaceutics 16 (1) (2024)
Mohamad Mroué, Flavien Bessaguet, Angélique Nizou, Laurence Richard, Franck G Sturtz, Laurent Magy, Sylvie Bourthoumieu, Aurore Danigo, Claire Demiot
Neuroprotective Effect of Polyvalent Immunoglobulins on Mouse Models of Chemotherapy-Induced Peripheral Neuropathy. Pharmaceutics 16 (1) (2024)
Amandine Bernard, Mohamad Mroué, Sylvie Bourthoumieu, Malcolm Boyce, Laurence Richard, Franck G Sturtz, Claire Demiot, Aurore Danigo
Netazepide, an Antagonist of Cholecystokinin Type 2 Receptor, Prevents Vincristine-Induced Sensory Neuropathy in Mice. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Amandine Bernard, Aurore Danigo, Mohamad Mroué, Amandine Rovini, Laurence Richard, Angélique Nizou, Alexis Desmoulière, Franck Sturtz, Claire Demiot, Sylvie Bourthoumieu
Blockade of Cholecystokinin Type 2 Receptors Prevents the Onset of Vincristine-Induced Neuropathy in Mice. Pharmaceutics 14 (12) (2022)
Amandine Bernard, Aurore Danigo, Mohamad Mroué, Amandine Rovini, Laurence Richard, Angélique Nizou, Alexis Desmoulière, Franck Sturtz, Claire Demiot, Sylvie Bourthoumieu
Blockade of Cholecystokinin Type 2 Receptors Prevents the Onset of Vincristine-Induced Neuropathy in Mice. Pharmaceutics 14 (12) (2022)
Amandine Bernard, Aurore Danigo, Mohamad Mroué, Amandine Rovini, Laurence Richard, Angélique Nizou, Alexis Desmoulière, Franck Sturtz, Claire Demiot, Sylvie Bourthoumieu
Blockade of Cholecystokinin Type 2 Receptors Prevents the Onset of Vincristine-Induced Neuropathy in Mice. Pharmaceutics 14 (12) (2022)
Amandine Bernard, Aurore Danigo, Mohamad Mroué, Amandine Rovini, Laurence Richard, Angélique Nizou, Alexis Desmoulière, Franck Sturtz, Claire Demiot, Sylvie Bourthoumieu
Blockade of Cholecystokinin Type 2 Receptors Prevents the Onset of Vincristine-Induced Neuropathy in Mice. Pharmaceutics 14 (12) (2022)
Amandine Bernard, Aurore Danigo, Sylvie Bourthoumieu, Mohamad Mroué, Alexis Desmoulière, Franck Sturtz, Amandine Rovini, Claire Demiot
The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management. Pharmaceuticals (Basel, Switzerland) 14 (11) (2021)